some reading on both dndn & onty, page-4

nngn
Spot on!

At the meeting we had with MR in late August, he made a point of mentioning ONTY's Stimuvax, indicating it was the next likely cancer vaccine to come onto the market.

If I recall correctly his words were along the lines of "their trial results could have important implications for Cvac".

I think one of the issues to be considered with this is the partnership with Merck. They have vast experience with the process of bringing new drugs and treatments to market. That being the case, I would imagine they will do a far better job of it than DNDN did with Provenge. (Having said that, it looks lke DNDN may finally be getting their act together and overcoming their initial marketing stuff up)

Cheers
K